Table 3.
Patterns of use of antihypertensive drugs among patients with and without IHD
| Drug class, N (%) | IHD (+) | IHD (-) | ||||
|---|---|---|---|---|---|---|
| Overall (%) n=109(100.0) | 1 Drug n= 45 (41.3) | ≥ 2 Drugs n= 53 (48.6) | Overall (%) n=146(100.0) | 1 Drug n=70(47.9) | ≥ 2 Drugs n=60(41.1) | |
| ACEIs / ARB | 65(59.6) | 25(55.6) | 40(75.5) | 92(63) | 44(62.9) | 48(80) |
| BB | 18(16.5) | 4(8.9) | 14(26.4) | 14(9.6) | 5(7.1) | 9(15) |
| CCB | 33(30.3) | 5(11.1) | 28(52.8) | 31(21.2) | 5(7.1) | 26(43.3) |
| Diuretics | 44(40.4) | 11(24.4) | 33(62.3) | 60(40.1) | 16(22.9) | 44(73.3) |
| α-blockers | 0.0(0.0) | 0.0(0.0) | 0.0(0.0) | 6 (4.1) | 0.0(0.0) | 4(6.7) |
| Total number of drugs | 160 | 45 | 115 | 203 | 70 | 133 |
Notes: 1. a group of 27 patients who were not on pharmacologic therapy were not included in the analysis.
2. “n” represents the number of patients.
3. IHD= ischemic heart disease, ACEIs/ ARB = angiotensin converting enzyme inhibitor/ angiotensin receptor blocker. BB = β-blocker, CCB = calcium channel blocker,